secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001705843-25-000010
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cibus Q2 net loss narrows to $26.6M; cash runway into Q2 2026; Rice trait commercialization on track
--------------------------------------------------------------------------------

- Net loss $26.6M ($0.61 per share) vs $28.5M ($1.14) YoY; R&D $12.2M, SG&A $6.6M, both down on cost cuts.
- Cash $36.5M at June 30; raised $27.5M gross from June offering; expects funding into Q2 2026.
- Streamlining targets annual cash usage ~$30M by 2026; focused on Rice herbicide tolerance and partner-funded programs.
- Rice HT1/HT3 traits on track for Latin America launch 2027, US 2028; signed collaboration with Colombia's Semillano; delivered HT3 lines to US customer.
- Sustainable ingredients program on track for nominal 2025 revenues; regulatory wins: Ecuador cleared HT1/HT3 as non-GMO, USDA deregulated HT2 canola.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000170584325000010/0001705843-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000170584325000010/cbus-20250814.htm
  HTML page:      https://secwatch.observer/filing/0001705843-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer